Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial. (nature.com)

Authors: Park W … O'Reilly EM Journal: Nature Medicine Published: 2026-05-01 DOI: https://doi.org/10.1038/s41591-026-04299-5